Inicia sesión Registrate Mi Biblioteca biblioteca abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

163045 ARTíCULOS , VIENDO DEL 64606 AL 64620

PUBMED

Blood and plasma-based proteomic biomarker research in Alzheimer's disease

Lista S, Faltraco F, Prvulovic D, Hampel H.

Prog Neurobiol. 2013 Feb-Mar;101-102:1-17. doi: 10.1016/j.pneurobio.2012.06.007. Epub 2012 Jun 26.

0

0

0

PUBMED

Prospective interest of molecular neuroimaging in Alzheimer's disease

Guedj E.

Rev Neurol (Paris). 2013 Jan;169(1):9-13. doi: 10.1016/j.neurol.2012.03.007. Epub 2012 Jun 6.

0

0

0

PUBMED

The development of effective biomarkers for Alzheimer's disease: a review

Henry MS, Passmore AP, Todd S, McGuinness B, Craig D, Johnston JA.

Int J Geriatr Psychiatry. 2013 Apr;28(4):331-40. doi: 10.1002/gps.3829. Epub 2012 Jun 4.

0

0

0

PUBMED

Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence?

Cunnane SC, Chouinard-Watkins R, Castellano CA, Barberger-Gateau P.

Prostaglandins Leukot Essent Fatty Acids. 2013 Jan;88(1):61-70. doi: 10.1016/j.plefa.2012.04.006. Epub 2012 May 9.

0

0

0

PUBMED

Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults

Nation DA, Edland SD, Bondi MW, Salmon DP, Delano-Wood L, Peskind ER, Quinn JF, Galasko DR.

Neurology. 2013 Dec 3;81(23):2024-7. doi: 10.1212/01.wnl.0000436935.47657.78. Epub 2013 Nov 13.

0

0

0

PUBMED

[Early diagnosis of Alzheimer's disease]

Seppälä T, Herukka SK, Remes AM.

Duodecim. 2013;129(19):2003-10.

0

0

0

PUBMED

[Biomarkers of the Alzheimer's disease: concepts and clinical case]

Bier JC.

Rev Med Brux. 2013 Sep;34(4):306-10.

0

0

0

PUBMED

Evaluation of symptomatic drug effects in Alzheimer's disease: strategies for prediction of efficacy in humans

Deguil J, Ravasi L, Auffret A, Babiloni C, Bartres Faz D, Bragulat V, Cassé-Perrot C, Colavito V, Herrero Ezquerro MT, Lamberty Y, Lanteaume L, Pemberton D, Pifferi F, Richardson JC, Schenker E, Blin

Drug Discov Today Technol. 2013 Sep;10(3):e329-42. doi: 10.1016/j.ddtec.2013.03.003.

0

0

0

PUBMED

Alzheimer's disease biomarkers: walk with deliberate haste, don't run blithely on?

Hu WT, Shaw LM, Trojanowski JQ.

Acta Neuropathol. 2013 Nov;126(5):625-9. doi: 10.1007/s00401-013-1197-3.

0

0

0

PUBMED

Molecular biomarkers of neurodegeneration

Höglund K, Salter H.

Expert Rev Mol Diagn. 2013 Nov;13(8):845-61. doi: 10.1586/14737159.2013.850033.

0

0

0

PUBMED

Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease

Forlenza OV, Diniz BS, Teixeira AL, Stella F, Gattaz W.

Braz J Psychiatry. 2013 Jul-Sep;35(3):284-94. doi: 10.1590/1516-4446-2012-3505.

0

0

0

PUBMED

Serum multivalent cationic pattern: speculation on the efficient approach for detection of Alzheimer's disease

Azhdarzadeh M, Noroozian M, Aghaverdi H, Akbari SM, Baum L, Mahmoudi M.

Sci Rep. 2013 Oct 10;3:2782. doi: 10.1038/srep02782.

0

0

0

PUBMED

[The DIAN study]

Shimada H.

Brain Nerve. 2013 Oct;65(10):1179-84.

0

0

0

PUBMED

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases

Gaiottino J, Norgren N, Dobson R, Topping J, Nissim A, Malaspina A, Bestwick JP, Monsch AU, Regeniter A, Lindberg RL, Kappos L, Leppert D, Petzold A, Giovannoni G, Kuhle J.

PLoS One. 2013 Sep 20;8(9):e75091. doi: 10.1371/journal.pone.0075091. eCollection 2013.

0

0

0

PUBMED

Biomarkers in Alzheimer's disease with a special emphasis on event-related oscillatory responses

Yener GG, Başar E.

Suppl Clin Neurophysiol. 2013;62:237-73. doi: 10.1016/b978-0-7020-5307-8.00020-x.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy